Sugentech Inc. (253840.KQ)
KOSDAQ · KRW · Healthcare · Medical Devices
₩4,065 (+0.87%) as of
Key statistics
- Market cap
- 62.15B
- Dividend yield
- 0.00%
- 52-week range
- 3,530.00 – 8,250.00
- Beta
- 0.57
- Revenue (TTM)
- 9.78B
- Profit margin
- -235.12%
- Volume
- 23.40k
About Sugentech Inc.
Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2, HbA1c, beta-hcg, YSH, T3/T4, and CRP; and digital health and home tests, including mobile health, ovulation, and pregnancy products. The company was formerly known as Accugen Healthcare, Inc. and changed its name to Sugentech Inc. in October 2013. Sugentech Inc. was founded in 2011 and is headquartered in Daejeon, South Korea.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Daejeon, South Korea
- Employees
- 148
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.